顯微外科手術機器人市場機會、成長動力、產業趨勢分析及2024年至2032年預測

Microsurgery Robot Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 to 2032

出版日期: 2024年11月11日 | 出版商:

Global Market Insights Inc. | 英文 100 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2023 年，全球顯微外科機器人市場價值為13 億美元，預計2024 年至2032 年將以13.9% 的複合年成長率強勁成長。。高風險手術對精確度的需求不斷增加，促進了機器人系統的採用，因為它們可以提高準確性、改善手術結果並減少人為錯誤。

全球人口老化是推動市場成長的另一個重要因素。與年齡相關的疾病，如白內障、心血管疾病和關節炎，需要精細的手術介入。機器人顯微手術系統提供更安全、微創的解決方案，確保患者更好的康復和滿意度。

市場依應用分為不同類別，包括腫瘤學、心血管、神經血管、重建和眼科手術等。其中，腫瘤學領域在 2023 年引領市場，創造了 2.849 億美元的收入。腫瘤學中的機器人系統提供無與倫比的精確度，使外科醫生能夠切除癌組織，同時保留周圍的健康組織。這種能力對於確保乾淨的邊緣和降低癌症復發的風險至關重要，特別是在敏感的解剖區域。

市場範圍
開始年份	2023年
預測年份	2024-2032
起始值	13億美元
預測值	42億美元
複合年成長率	13.9%

就最終用途而言，市場分為醫院和診所、門診手術中心、研究機構和其他設施。醫院和診所將在 2023 年成為主導領域，預計到 2032 年將達到 22 億美元。學操作。隨著醫療機構尋求現代化和保持競爭力，技術進步，包括將人工智慧和資料分析整合到機器人平台中，進一步增強了它們的價值。

2023 年，北美地區的收入為 7.375 億美元，預計在預測期內複合年成長率為 13.2%。該地區的成長得益於人口老化、對微創解決方案不斷成長的需求以及強大的私人醫療基礎設施。私人醫院和診所對尖端技術的高額投資使北美成為採用顯微手術機器人的領跑者。

產業生態系統分析
產業影響力
- 成長動力
  - 對微創外科手術的需求不斷增加
  - 技術進步
  - 慢性病發生率上升
  - 已開發國家加大顯微手術機器人研發資金投入
- 產業陷阱與挑戰
  - 與機器人系統相關的高成本
  - 缺乏熟練的醫療保健專業人員
成長潛力分析
監管環境
報銷場景
技術景觀
波特的分析
PESTEL分析
啟動場景
政策展望
未來市場趨勢
差距分析

第 4 章：競爭格局

介紹
公司矩陣分析
公司市佔率分析
主要參與者的競爭分析
競爭定位矩陣
戰略儀表板

第 5 章：市場估計與預測：按應用分類，2021 - 2032 年

主要趨勢
腫瘤手術
泌尿科
婦產科手術
顯微吻合術
重建手術
耳鼻喉科手術
胃腸外科
心血管外科
輸尿管腎鏡檢查
神經血管外科
眼科手術
其他應用

第 6 章：市場估計與預測：依最終用途，2021 - 2032 年

主要趨勢
醫院和診所
門診手術中心
科學研究機構
其他最終用戶

第 7 章：市場估計與預測：按地區分類，2021 - 2032 年

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 荷蘭
亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 韓國
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
中東和非洲
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國

第 8 章：公司簡介

Asensus Surgical
avateramedical
CMR Surgical
Distalmotion
Intuitive Surgical
Johnson & Johnson (Ethicon)
Medical Microinstruments
Medtronic
meerecompany
MicroSure
Siemens Healthineers
Smith & Nephew
Stryker Corporation
Titan Medical
Zimmer Biomet

簡介目錄

Product Code: 2814

The Global Microsurgery Robot Market was valued at USD 1.3 billion in 2023 and is projected to grow at a robust CAGR of 13.9% from 2024 to 2032. The market expansion is driven by the rising prevalence of chronic diseases, advancements in surgical technologies, a shortage of skilled surgeons, and favorable reimbursement policies. Increasing demand for precision in high-stakes surgeries boosts the adoption of robotic systems, as these offer enhanced accuracy, improved surgical outcomes, and reduced human error.

The aging global population is another significant factor fueling market growth. Age-related conditions, such as cataracts, cardiovascular diseases, and arthritis, require delicate surgical interventions. Robotic microsurgery systems provide safer, minimally invasive solutions, ensuring better patient recovery and satisfaction.

The market is segmented by application into various categories, including oncology, cardiovascular, neurovascular, reconstructive, and ophthalmology surgeries, among others. Among these, the oncology segment led the market in 2023, generating USD 284.9 million in revenue. Robotic systems in oncology offer unparalleled precision, enabling surgeons to remove cancerous tissues while preserving surrounding healthy tissues. This capability is critical in ensuring clean margins and reducing the risk of cancer recurrence, especially in sensitive anatomical regions.

Market Scope
Start Year	2023
Forecast Year	2024-2032
Start Value	$1.3 Billion
Forecast Value	$4.2 Billion
CAGR	13.9%

In terms of end-use, the market is divided into hospitals and clinics, ambulatory surgical centers, research institutes, and other facilities. Hospitals and clinics emerged as the dominant segment in 2023 and are projected to reach USD 2.2 billion by 2032. The adoption of robotic systems in hospitals is driven by their ability to enhance the accuracy and efficiency of complex procedures, such as cardiac, neurosurgical, and oncology operations. Technological advancements, including the integration of AI and data analytics into robotic platforms, are further augmenting their value as healthcare institutions seek to modernize and remain competitive.

North America accounted for USD 737.5 million in revenue in 2023 and is expected to grow at a CAGR of 13.2% during the forecast period. The region's growth is propelled by its aging population, increasing demand for minimally invasive solutions, and a strong private healthcare infrastructure. High investment in cutting-edge technologies by private hospitals and clinics has made North America a frontrunner in adopting microsurgery robots.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increasing demand for minimally invasive surgical procedures
  - 3.2.1.2 Technological advancements
  - 3.2.1.3 Rising incidences of chronic conditions
  - 3.2.1.4 Increasing funding for development of microsurgery robots in developed countries
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 High cost associated with robotic systems
  - 3.2.2.2 Dearth of skilled healthcare professionals
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Reimbursement scenario
3.6 Technology landscape
3.7 Porter's analysis
3.8 PESTEL analysis
3.9 Start-up scenario
3.10 Policy outlook
3.11 Future market trends
3.12 Gap analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive analysis of major key players
4.5 Competitive positioning matrix
4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Oncology surgery
5.3 Urology surgery
5.4 Obstetrics and gynecology surgery
5.5 Micro anastomosis
5.6 Reconstructive surgery
5.7 ENT surgery
5.8 Gastrointestinal surgery
5.9 Cardiovascular surgery
5.10 Ureterorenoscopy
5.11 Neurovascular surgery
5.12 Ophthalmology surgery
5.13 Other applications

Chapter 6 Market Estimates and Forecast, By End Use, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Hospitals and clinics
6.3 Ambulatory surgical centers
6.4 Research institutes
6.5 Other end users

Chapter 7 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 North America
- 7.2.1 U.S.
- 7.2.2 Canada
7.3 Europe
- 7.3.1 Germany
- 7.3.2 UK
- 7.3.3 France
- 7.3.4 Spain
- 7.3.5 Italy
- 7.3.6 Netherlands
7.4 Asia Pacific
- 7.4.1 China
- 7.4.2 Japan
- 7.4.3 India
- 7.4.4 Australia
- 7.4.5 South Korea
7.5 Latin America
- 7.5.1 Brazil
- 7.5.2 Mexico
- 7.5.3 Argentina
7.6 Middle East and Africa
- 7.6.1 South Africa
- 7.6.2 Saudi Arabia
- 7.6.3 UAE